| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |